Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on June 2, 2025
Turtle Beach Corporation to Participate in Fireside Chat Hosted by Maxim Group
GlobeNewswire
·
June 2, 2025
SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Turtle Beach Corporation (Nasdaq: TBCH), a leading gaming accessories brand, today announced that Cris Keirn, Chief Executive Officer, and Mark Weinswig, Chief Financial Officer, will participate in a fireside …
Sernova Appoints Jonathan Rigby as Interim Chair
GlobeNewswire
·
June 2, 2025
LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functional cure for type 1 …
Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer
GlobeNewswire
·
June 2, 2025
WALTHAM, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
Cardiff Oncology Announces Positive Data from Investigator-Initiated Trial of Onvansertib in Combination with Paclitaxel in Metastatic Triple-Negative Breast Cancer Presented at ASCO 2025
GlobeNewswire
·
June 2, 2025
– Results from Phase 1b clinical trial evaluating onvansertib + paclitaxel for metastatic triple negative breast cancer demonstrated 40% objective response rate – – The trial evaluated three doses of onvansertib in combination with paclitaxel, and …
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 2, 2025
BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on May 30, 2025, the company issued inducement awards to …
Abivax Presents First Quarter 2025 Financial Results
GlobeNewswire
·
June 2, 2025
Abivax Presents First Quarter 2025 Financial Results PARIS, France, June 2, 2025, 10:00 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing …
Best Bitcoin (BTC) Cloud Mining Option in 2025: Earn Mining Stands Out
GlobeNewswire
·
June 2, 2025
Miami, Florida, United States, June 02, 2025 (GLOBE NEWSWIRE) -- With the continuous advancement of artificial intelligence and the continued rise of the cryptocurrency market, cloud mining is accelerating towards efficiency, intelligence and …
Cronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Consumer Conference
GlobeNewswire
·
June 2, 2025
TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the TD Cowen 9th …
X Payments Beta Sparks Dogecoin Frenzy, PFM CRYPTO Dogecoin Mining Sees Golden Entry Opportunity
GlobeNewswire
·
June 2, 2025
New York City, NY, June 02, 2025 (GLOBE NEWSWIRE) -- In 2025, cryptocurrencies are playing an increasingly important role in the payment field. Recently, the X Payments feature will soon begin limited testing, triggering a sharp surge in Dogecoin’s price. …
Coloradans Can Share Their Favorite Homes Instantly with Houzeo’s ‘Smart Sharing’ Feature
EIN Presswire
·
June 2, 2025
Home shoppers can now effortlessly share their favorite homes with the people who matter most—thanks to Houzeo DENVER, CO, UNITED STATES, June 1, 2025 /EINPresswire.com/ -- Houzeo, America’s leading Real Estate Super App, is reshaping the home-buying …
Rapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate Updates
GlobeNewswire
·
June 2, 2025
BOSTON and SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …
Litecoin’s ZK Omnichain ‘LitVM’ Unveiled at Litecoin Summit
GlobeNewswire
·
June 2, 2025
Las Vegas, NV, June 02, 2025 (GLOBE NEWSWIRE) -- Lunar Digital Assets, the leading full stack blockchain venture studio announced the launch of LitVM, the first EVM-compatible Layer 2 built on Litecoin at the Litecoin Summit. LitVM is a trustless zero- …
Elite Clinical Network Appoints Christopher Brennan as Chief Executive Officer
GlobeNewswire
·
June 2, 2025
SCOTTSDALE, Ariz., June 02, 2025 (GLOBE NEWSWIRE) -- Elite Clinical Network (ECN), a fully-integrated clinical research site network, has appointed Christopher (“Chris”) Brennan as its Chief Executive Officer. With 25 years of leadership experience at …
Snail Games Celebrates ARK Franchise’s 10-Year Anniversary with New Content and Global Community Events
GlobeNewswire
·
June 2, 2025
CULVER CITY, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, is proud to commemorate the 10-year anniversary …
Quantum eMotion Closes Brokered LIFE Financing of $12,000,000
GlobeNewswire
·
June 2, 2025
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES MONTREAL, June 02, 2025 (GLOBE NEWSWIRE) -- Quantum eMotion Corp. (“QeM” or the “Corporation”) (TSX.V: QNC; OTCQB: QNCCF; F: 34Q0) is pleased to announce that it has …
ETHRANSACTION 2025 Launches Multi-Crypto Cloud Mining Solution
GlobeNewswire
·
June 2, 2025
York, England, June 02, 2025 (GLOBE NEWSWIRE) -- As the times change, people's ideas about energy are also evolving. Today, people rely on renewable energy such as solar and wind energy to drive new energy cloud mining business. Thanks to this, the cost of …
OSE Immunotherapeutics fait un point clinique sur Tedopi®, vaccin contre le cancer à base de néo-épitopes, dans le cancer du pancréas et dans le cancer du poumon non à petites cellules
GlobeNewswire
·
June 2, 2025
OSE Immunotherapeutics fait un point clinique sur Tedopi®, vaccin contre le cancer à base de néo-épitopes, dans le cancer du pancréas et dans le cancer du poumon non à petites cellules Deux présentations au congrès 2025 de l’ASCO (American Society of …
OSE Immunotherapeutics Provides Clinical Updates on Neo-Epitope Based Cancer Vaccine Tedopi® in Pancreatic Cancer and Non-Small Cell Lung Cancer
GlobeNewswire
·
June 2, 2025
OSE Immunotherapeutics Provides Clinical Updates on Neo-Epitope Based Cancer Vaccine Tedopi® in Pancreatic Cancer and Non-Small Cell Lung Cancer Two presentations at the American Society of Clinical Oncology (ASCO) 2025: TEDOPaM - Phase 2 first positive …
Sword Group : Signature de 6 nouveaux contrats prestigieux long terme
GlobeNewswire
·
June 2, 2025
Signature de 6 nouveaux contrats prestigieux long terme Des contrats stratégiques dans les secteurs clés du Groupe, pour une visibilité renforcée Ces engagements récents illustrent la pertinence de la stratégie du Groupe et sa capacité à accompagner …
Sword Group: Signing of 6 Prestigious Long-Term Contracts
GlobeNewswire
·
June 2, 2025
Signing of 6 Prestigious Long-Term Contracts Strategic Agreements in the Group’s Key Sectors, Reinforcing Visibility These recent engagements reflect the relevance of the Group’s strategy and its ability to support clients over the long term through major …